Purdue’s Sacklers, States Reach Opioid Deal Valued at Up to $6 Billion
Opioid Crisis,Purdue Pharma,Sackler Family,Business,Courts,Healthcare,Drugs,Public Health
From the Center
AllSides Media Bias Rating: Center
Members of the Sackler family who own Purdue Pharma LP and grew wealthy from sales of OxyContin agreed to give back $6 billion to settle lawsuits accusing them of helping fuel the opioid epidemic, earning the unanimous support of state attorney generals to resolve their liability and end the company’s bankruptcy case.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
Related Coverage
AllSides Picks
Headline Roundup
California Faces Additional $1.2 Billion Medicaid Funding Freeze Amid Fraud Allegations
October 21st, 2026
Red Blue Translator
FDA (U.S. Food & Drug Administration)
Red Blue Translator
Affordable Care Act
Recommended Reading
What Does America Look Like From Main Street?
Guest Writer
October 19th, 2026